John E. Gerich

37.4k citations
349 papers · 31.4k · 10 hit papers · h-index 98

Impact in

    • Diabetes Management and Research
    • Diabetes Treatment and Management
    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Growth Hormone and Insulin-like Growth Factors
    • Diet, Metabolism, and Disease
  • Surgery top 0.1%
    • Pancreatic function and diabetes

Papers in

    • Diabetes Management and Research 149
    • Diabetes Treatment and Management 66
    • Diabetes, Cardiovascular Risks, and Lipoproteins 51
    • Growth Hormone and Insulin-like Growth Factors 16
    • Diet, Metabolism, and Disease 14
    • Pancreatic function and diabetes 163

John E. Gerich

343 papers receiving 28.5k citations

John E. Gerich's Hit Papers

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) 2009 · 729 citations
7290+17+35Years since publication4008001.2k

Peers

John E. Gerich
Comparison fields: 5 of 152
  • Endocrinology, Diabetes and Metabolism 18.1k
  • Surgery 8k
  • Endocrine and Autonomic Systems 870
  • Nephrology 1.1k
  • Biochemistry 701
Replace Ralph A. DeFronzo with:
Ralph A. DeFronzo United States
Philip E. Cryer United States
Johannes Anthonius Romijn Netherlands
William Timothy Garvey United States
Bo Åhrén Sweden
Hannele Yki‐Järvinen Finland
Aram S. Rudenski United Kingdom
Ralph Anthony DeFronzo United States
John P. Hosker United Kingdom
Eleuterio Ferrannini Italy
John E. Gerich relative to Ralph A. DeFronzo United States Ralph A. DeFronzo's profile →
Citations per field
00.5×1.5×
Ralph A. DeFronzo · 1×
Citations per year

Countries citing papers authored by John E. Gerich

Since Specialization
Citations

This map shows the geographic impact of John E. Gerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Gerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Gerich more than expected).

Fields of papers citing papers by John E. Gerich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Gerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Gerich. The network helps show where John E. Gerich may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Gerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Gerich Line = papers co-authored together John E. Gerich links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 349 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Treat-to-Target Trial
Hit paper breakdown →
20031224
2
Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes Mellitus
Hit paper breakdown →
1995941
3
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
Hit paper breakdown →
2000888
4
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Hit paper breakdown →
2009729
5
Cortisol-Induced Insulin Resistance in Man: Impaired Suppression of Glucose Production and Stimulation of Glucose Utilization due to a Postreceptor Defect of Insulin Action*
Hit paper breakdown →
1982596
6
Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect
Hit paper breakdown →
1973593
7
Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance
Hit paper breakdown →
1992506
8
Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications
Hit paper breakdown →
2009506
9 2001487
10 1991459
11 1989418
12
Effects of Growth Hormone on Insulin Action in Man: Mechanisms of Insulin Resistance, Impaired Suppression of Glucose Production, and Impaired Stimulation of Glucose Utilization
Hit paper breakdown →
1982384
13
Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Hit paper breakdown →
1979365
14 1983364
15 1998353
16 1989352
17 1988329
18 2007318
19 1983306
20 1980304

About John E. Gerich

John E. Gerich is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Biochemistry, Cell Biology and Molecular Biology, having authored 349 papers that have together received 31.4k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (163 papers), Diabetes Management and Research (149 papers), Diabetes Treatment and Management (66 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (51 papers), Metabolism, Diabetes, and Cancer (32 papers), Muscle metabolism and nutrition (17 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Diet, Metabolism, and Disease (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (18.1k citations), Surgery (8k citations), Endocrine and Autonomic Systems (870 citations), Nephrology (1.1k citations) and Biochemistry (701 citations). John E. Gerich has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Robert A. Rizza, Michael Stümvoll, Lawrence J. Mandarino, Asimina Mitrakou, Philip E. Cryer, Nurjahan Nurjhan, Morey W. Haymond, Gabriele Perriello, Peter H. Forsham and Geremia B. Bolli. Their work appears in journals such as Diabetes, Metabolism, American Journal of Physiology-Endocrinology and Metabolism, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact